US
Europe (English)
Chinese
JapaneseTARGETED RESEQUENCING
Targeted resequencing is an effective method for analyzing your selected gene(s) of interest by next generation sequencing. Whether you are interested in a few genes, or a few hundred genes, targeted resequencing panels offer high sensitivity and specificity, providing in-depth coverage, resulting in high-quality data.
With targeted resequencing gene panels, you can discover point mutations, insertions/deletions (INDELs), copy number variations (CNVs), and gene rearrangements.
Targeted Resequencing Gene Panels
Azenta provides a variety of targeted resequencing panels, either pre-made or custom, that can cover any genes of interest or cancer-implicated genes.
Visit these pages to learn more about these services:
-
Cancer Panels
Including commercially available hotspot cancer panels, as well as Azenta’s pan-cancer and OncoGxOne™ discovery cancer panels.
-
TargetGxOne™ Custom Gene Panels
Our custom panels can be designed to target any genes of your choosing.
-
Whole Exome Sequencing
A cost-effective alternative to whole genome sequencing, which allows genetic analysis of genomic coding regions.
Applications
Features & Benefits
Workflow for Targeted Resequencing Panels
-
Experimental Design
1 -
-
Targeting and Library Preparation
2 -
-
Sequencing
3 -
-
Bioinformatics
4
Sample Submission Guidelines
Azenta accepts the following sample types for targeted resequencing projects:
- Purified genomic DNA
- Frozen cell pellets (mammalian or bacterial)
- PCR amplicons
- Bacterial colonies
- Formalin-fixed, paraffin-embedded (FFPE) thin sections (slides)
- Select tissues
- Blood
- Swab
Technical Resources
Blog | NGS, qPCR, or Sanger Sequencing: An Assay Selection Guide
This selection guide offers practical information about PCR + Sanger, qPCR, and NGS approaches to help you determine which assay best suits your project requirements, along with an interactive assay selection tool to aid your decision making.
Webinar| Non-Classical Sources of Tumour-Specific Antigen in Checkpoint Inhibitor Response
Developing immunotherapies for cancer can be difficult due to the variation of immune response from patient to patient. In this webinar, Dr. Litchfield from UCL Cancer Institute presents his team’s exploratory research using a multiomics approach to better understand the diversity of immune response to cancer and highlights their findings of an alternative source of a tumour-specific antigen in checkpoint inhibitor (CPI) response.
Webinar | Demystifying End-to-End DNA Sequencing Solutions
In this co-hosted webinar with Twist Bioscience, learn how researchers design custom panels to sequence deeply and efficiently into regions, genes, and organisms of interest, as well as gain a greater understanding on how targeted sequencing can be combined with the latest transcriptomics and proteomics tools to reveal even more insights.
NGS Platforms
Azenta is a certified service provider for Illumina and Life Technology NGS platforms. For information on our NGS platforms as well as recommended configurations for your projects, please visit the NGS Platforms page. Azenta does not guarantee data output or quality for sequencing only projects.
